250 related articles for article (PubMed ID: 11956873)
1. Utility of hemodialysis in maple syrup urine disease.
Puliyanda DP; Harmon WE; Peterschmitt MJ; Irons M; Somers MJ
Pediatr Nephrol; 2002 Apr; 17(4):239-42. PubMed ID: 11956873
[TBL] [Abstract][Full Text] [Related]
2. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
McMahon Y; MacDonnell RC
Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
[TBL] [Abstract][Full Text] [Related]
3. Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment.
Gouyon JB; Desgres J; Mousson C
Pediatr Res; 1994 Mar; 35(3):357-61. PubMed ID: 8190527
[TBL] [Abstract][Full Text] [Related]
4. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
[TBL] [Abstract][Full Text] [Related]
5. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
6. [Continuous arteriovenous hemofiltration. Management in case of neonatal leucinosis].
Casadevall I; Ogier H; Germain JF; Daoud P; Hartmann JF; Mercier JC; Beaufils F
Arch Fr Pediatr; 1992 Nov; 49(9):803-5. PubMed ID: 1300969
[TBL] [Abstract][Full Text] [Related]
7. [Maple syrup urine disease and cystathioninemia].
Simma B; Sperl W; Berger H
Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
[TBL] [Abstract][Full Text] [Related]
8. [Hemofiltration in acute neonatal metabolic crisis].
Ring E; Zobel G
Wien Klin Wochenschr; 1992; 104(21):674-7. PubMed ID: 1475972
[TBL] [Abstract][Full Text] [Related]
9. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
Lie IE; Haugstad S; Holm H
Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
11. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease.
Wu JY; Kao HJ; Li SC; Stevens R; Hillman S; Millington D; Chen YT
J Clin Invest; 2004 Feb; 113(3):434-40. PubMed ID: 14755340
[TBL] [Abstract][Full Text] [Related]
12. Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.
Simon E; Wendel U; Schadewaldt P
Turk J Pediatr; 2005; 47(1):8-13. PubMed ID: 15884622
[TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease in Thai infants.
Pangkanon S; Charoensiriwatana W; Sangtawesin V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
[TBL] [Abstract][Full Text] [Related]
14. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
Parini R; Sereni LP; Bagozzi DC; Corbetta C; Rabier D; Narcy C; Hubert P; Saudubray JM
Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
[No Abstract] [Full Text] [Related]
15. Restoration of brain stem auditory-evoked potential in maple syrup urine disease.
Spankovich C; Lustig LR
Otol Neurotol; 2007 Jun; 28(4):566-9. PubMed ID: 17414178
[TBL] [Abstract][Full Text] [Related]
16. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
Tain YL; Huang SC; Hung FC; Wang HS; Sun PC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
[TBL] [Abstract][Full Text] [Related]
18. Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.
Aygün F; Kıykım E; Aktuğlu-Zeybek Ç; Zubarioğlu T; Cam H
Turk J Pediatr; 2019; 61(1):107-110. PubMed ID: 31559730
[TBL] [Abstract][Full Text] [Related]
19. A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies.
Bridi R; Fontella FU; Pulrolnik V; Braun CA; Zorzi GK; Coelho D; Wajner M; Vargas CR; Dutra-Filho CS
J Neurosci Methods; 2006 Sep; 155(2):224-30. PubMed ID: 16530844
[TBL] [Abstract][Full Text] [Related]
20. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
